• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对巨细胞动脉炎和高安动脉炎有用的实验室检查。

Laboratory investigations useful in giant cell arteritis and Takayasu's arteritis.

作者信息

Salvarani C, Cantini F, Boiardi L, Hunder G G

机构信息

Rheumatology Service, Arcispedale S. Maria Nuova, V.le Umberto 1o N50, 42100 Reggio Emilia, Italy.

出版信息

Clin Exp Rheumatol. 2003 Nov-Dec;21(6 Suppl 32):S23-8.

PMID:14740424
Abstract

A raised erythrocyte sedimentation rate (ESR) is considered a hallmark for the diagnosis of giant cell arteritis (GCA). The American College of Rheumatology 1990 criteria for GCA include ESR greater than or equal to 50 mm/h as one of the five criteria. Although the presence of a normal ESR made GCA less likely, the results of a population-based study showed that the occurrence of a low/normal value in GCA at diagnosis is not rare. Pre-treatment ESR may be a prognostic indicator for duration of treatment. C-reactive protein (CRP) and interleukin-6 (IL-6) may be more sensitive indicators of disease activity than ESR in GCA patients. However, it is unclear whether the use in clinical practice of CRP and IL-6 has some apparent advantage over ESR. ESR is the most often used tool to assess disease activity in Takayasu's arteritis (TA). However, some studies have found that ESR and CRP are not able to differentiate patients with clinically active and inactive TA. Furthermore, histopathological studies have shown that over 40% of patients thought to be in clinical remission with normal acute phase reactants have active arteritis. IL-6 could be a promising marker of disease activity in TA; however, further studies are required to confirm its usefulness in clinical practice. Other laboratory investigations could be useful in the diagnosis or follow-up of GCA and TA, but more studies are required.

摘要

红细胞沉降率(ESR)升高被认为是巨细胞动脉炎(GCA)诊断的一个标志。美国风湿病学会1990年GCA诊断标准包括ESR大于或等于50mm/h作为五项标准之一。虽然ESR正常使GCA的可能性降低,但一项基于人群的研究结果表明,GCA诊断时出现低/正常ESR值并不罕见。治疗前ESR可能是治疗持续时间的一个预后指标。在GCA患者中,C反应蛋白(CRP)和白细胞介素-6(IL-6)可能比ESR更能敏感地反映疾病活动。然而,尚不清楚CRP和IL-6在临床实践中的应用是否比ESR具有明显优势。ESR是评估大动脉炎(TA)疾病活动最常用的工具。然而,一些研究发现,ESR和CRP无法区分临床活动期和非活动期的TA患者。此外,组织病理学研究表明,超过40%被认为处于临床缓解期且急性期反应物正常的患者存在活动性动脉炎。IL-6可能是TA疾病活动的一个有前景的标志物;然而,需要进一步研究以证实其在临床实践中的有用性。其他实验室检查可能对GCA和TA的诊断或随访有用,但还需要更多研究。

相似文献

1
Laboratory investigations useful in giant cell arteritis and Takayasu's arteritis.对巨细胞动脉炎和高安动脉炎有用的实验室检查。
Clin Exp Rheumatol. 2003 Nov-Dec;21(6 Suppl 32):S23-8.
2
Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.是否存在糖皮质激素抵抗性大血管血管炎(巨细胞动脉炎和 Takayasu 动脉炎),如何实现缓解?文献综述。
Clin Exp Rheumatol. 2012 Jan-Feb;30(1 Suppl 70):S114-29. Epub 2012 May 11.
3
Clinical differentiation between giant cell (temporal) arteritis and Takayasu's arteritis.巨细胞(颞)动脉炎与高安动脉炎的临床鉴别
J Rheumatol. 1996 Jan;23(1):106-11.
4
Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis.经活检证实的巨细胞动脉炎中C反应蛋白正常而红细胞沉降率升高的患病率。
Ophthalmology. 2006 Oct;113(10):1842-5. doi: 10.1016/j.ophtha.2006.05.020. Epub 2006 Aug 1.
5
[Takayasu's arteritis and giant cell arteritis].
Ryoikibetsu Shokogun Shirizu. 1994(4):590-3.
6
[Large-vessel vasculitides].[大血管血管炎]
Duodecim. 2011;127(15):1539-47.
7
Giant cell arteritis with an erythrocyte sedimentation rate lower than 50.红细胞沉降率低于50的巨细胞动脉炎
Clin Rheumatol. 2000;19(1):73-5. doi: 10.1007/s100670050017.
8
New-onset giant cell arteritis with lower ESR and CRP level carries a similar ischemic risk to other forms of the disease but has an excellent late prognosis: a case-control study.红细胞沉降率(ESR)和C反应蛋白(CRP)水平较低的新发巨细胞动脉炎与其他形式的疾病具有相似的缺血风险,但预后良好:一项病例对照研究
Rheumatol Int. 2023 Jul;43(7):1323-1331. doi: 10.1007/s00296-023-05299-1. Epub 2023 Apr 7.
9
[Long-term complications, monitoring and interventional treatment of large vessel vasculitis].[大血管血管炎的长期并发症、监测与介入治疗]
Z Rheumatol. 2020 Aug;79(6):523-531. doi: 10.1007/s00393-020-00807-1.
10
Systematic review of the literature and a case report informing biopsy-proven giant cell arteritis (GCA) with normal C-reactive protein.文献系统回顾及病例报告:证实活检的巨细胞动脉炎(GCA)伴正常 C 反应蛋白。
Clin Rheumatol. 2012 Sep;31(9):1389-93. doi: 10.1007/s10067-012-2031-3. Epub 2012 Jul 22.

引用本文的文献

1
Development of the Takayasu Arteritis Integrated Disease Activity Index.Takayasu 动脉炎综合疾病活动指数的制定。
Arthritis Care Res (Hoboken). 2024 Apr;76(4):531-540. doi: 10.1002/acr.25275. Epub 2024 Jan 26.
2
Surgical intervention of Takayasu's arteritis with supraaortic arterial occlusive disease and critical ischemia of upper extremity: A case report.伴有主动脉弓上动脉闭塞性疾病及上肢严重缺血的大动脉炎的外科干预:一例报告
SAGE Open Med Case Rep. 2023 Oct 10;11:2050313X231205138. doi: 10.1177/2050313X231205138. eCollection 2023.
3
Leucine-rich alpha-2 glycoprotein as a potential biomarker for large vessel vasculitides.
富含亮氨酸的α-2糖蛋白作为大血管血管炎的潜在生物标志物。
Front Med (Lausanne). 2023 May 5;10:1153883. doi: 10.3389/fmed.2023.1153883. eCollection 2023.
4
Characteristics of Older Patients with Takayasu's Arteritis: A Two-Center, Cross-Sectional, Retrospective Cohort Study.老年 Takayasu 动脉炎患者的特征:一项两中心、横断面、回顾性队列研究。
Arq Bras Cardiol. 2023 Jan 9;120(1):e20220463. doi: 10.36660/abc.20220463. eCollection 2023.
5
Predictors of complete 24-month remission and flare in patients with polymyalgia rheumatica.风湿性多肌痛患者24个月完全缓解和复发的预测因素。
Clin Exp Med. 2023 Nov;23(7):3391-3397. doi: 10.1007/s10238-022-00976-0. Epub 2022 Dec 24.
6
Takayasu arteritis - epidemiology, pathogenesis, diagnosis and treatment.高安动脉炎——流行病学、发病机制、诊断与治疗
J Appl Biomed. 2019 Mar;17(1):20. doi: 10.32725/jab.2018.005. Epub 2019 Jan 9.
7
The study of novel inflammatory markers in takayasu arteritis and its correlation with disease activity.探讨大动脉炎新型炎症标志物及其与疾病活动的相关性。
Indian Heart J. 2021 Sep-Oct;73(5):640-643. doi: 10.1016/j.ihj.2021.08.002. Epub 2021 Aug 13.
8
Five-day fever: The main presentation of childhood-onset Takayasu arteritis.五日热:儿童期发病的高安动脉炎的主要表现。
Clin Case Rep. 2020 Jul 15;8(12):2361-2365. doi: 10.1002/ccr3.3148. eCollection 2020 Dec.
9
Targeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients.针对 COVID-19 患者肺部炎症和心血管并发症的免疫系统靶向治疗。
Front Immunol. 2020 Jun 23;11:1439. doi: 10.3389/fimmu.2020.01439. eCollection 2020.
10
Pulmonary artery involvement in Takayasu arteritis: a retrospective study in Chinese population.大动脉炎中肺动脉受累情况:一项针对中国人群的回顾性研究
Clin Rheumatol. 2021 Feb;40(2):635-644. doi: 10.1007/s10067-020-05271-5. Epub 2020 Jul 8.